fda compounding glp-1 enforcement news november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our The New York Times spotlighted

This formula combines vitamins, minerals, and our HM5 MenoControl Complex that helps you manage menopause symptoms, supports your thyroid, helps regulate metabolism, and supports healthy skin & hair

muciniphila supplementation demonstrates therapeutic efficacy in improving insulin sensitivity in obese and type 2 diabetic patients, and shows potential in mitigating Parkinson's disease pathology by regulating -synuclein oligomerization

Magnesium calms the nervous system

Selecting the right patients for GLP-1 therapy and monitoring them closely is key to ensuring safety and optimizing outcomes

GLP-1 receptor agonists do not have direct effects on bladder function or structure, as GLP-1 receptors are not significantly expressed in bladder tissue

Learn how to choose the best probiotics for GLP-1 users to manage digestive side effects like bloating, constipation, and reflux with expert-backed strain and dosing tips.